During Matthew 4
4 · Ovid Therapeutics Inc. · Filed Apr 3, 2019
Insider Transaction Report
Form 4
During Matthew
DirectorPresident and CSO10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2019-04-01+75,000→ 75,000 totalExercise: $1.76Exp: 2029-03-31→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]25% of the shares will become exercisable immediately and the remaining shares shall vest monthly thereafter over subsequent three years subject to the Reporting Person's continued service through such date.